Basic Information
AIxMed is an early-stage intelligent cytology company. AIxMed helps pathologists digitize cytology samples in minutes and extract clinical insights in seconds to improve patient diagnosis and care. Its first application, AIxURO, is an AI-assisted urine cytology imaging and reporting software package based on The Paris System (TPS) for bladder cancer diagnosis and monitoring. The company recently completed a pilot study, with results published in Cancer Cytopathology.
AIxMed, Inc.
California,United States of America
15~50 people
June 01, 2018
--

